GO:0035470 positive regulation of vascular wound healing: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035470 (positive regulation of vascular wound healing) is a biological process that increases the rate, frequency, or extent of new blood vessel formation from pre-existing vessels to restore damaged vasculature.
• Key molecular drivers include Piezo1, which senses matrix stiffness and promotes angiogenesis in hepatocellular carcinoma, and skeletal endothelial cells that support bone regeneration.
• The process is regulated by mechanotransduction, growth factors, and immune cell crosstalk, with macrophages and CAR-TREM2 cells playing pro-regenerative roles.
• Dysregulation contributes to cancer progression, chronic wounds, and impaired bone healing, making it a therapeutic target.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect gene function in vascular wound healing.
• EDITGENE provides comprehensive CRISPR services including library screening and bioinformatics to accelerate research in this field.
Description
Positive regulation of vascular wound healing (GO:0035470) is a biological process that increases the rate, frequency, or extent of blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to damaged vasculature. This process is critical for tissue repair, regeneration, and homeostasis, and its dysregulation is implicated in numerous pathologies including cancer, chronic wounds, and bone loss. Understanding the molecular mechanisms that positively regulate vascular wound healing is essential for developing targeted therapies. Recent studies have identified key players such as Piezo1, a mechanosensitive ion channel that promotes angiogenesis in response to matrix stiffness in hepatocellular carcinoma, and skeletal endothelial cells that support bone regeneration. Additionally, immunomodulatory hydrogels and CAR-TREM2-macrophages have been shown to orchestrate pro-regenerative responses and angiogenesis for chronic wound healing and scar management. These findings highlight the complexity of the process and the need for robust experimental models to study gene function. This article provides a comprehensive overview of GO:0035470, covering its definition, mechanisms, key genes, disease relevance, and research methodologies, with a focus on CRISPR-based approaches for functional genomics.
positive regulation of vascular wound healing At A Glance
| GO ID | GO:0035470 |
|---|---|
| GO term | positive regulation of vascular wound healing |
| Ontology | biological_process |
| Synonym | none |
| Major function | Increases the rate, frequency, or extent of blood vessel formation from pre-existing vessels to restore damaged vasculature |
| Related process | Angiogenesis, vascular wound healing, endothelial cell proliferation and migration |
| Key regulators | Piezo1, skeletal endothelial cells, macrophages, CAR-TREM2 cells |
| Disease relevance | Cancer, chronic wounds, bone loss, scar formation |
What Is GO:0035470?
GO:0035470, positive regulation of vascular wound healing, is defined as any process that increases the rate, frequency, or extent of blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to damaged vasculature. In simpler terms, it encompasses the molecular and cellular events that boost the growth of new blood vessels from existing ones to repair injured blood vessels. This process is a positive regulatory component of vascular wound healing, ensuring efficient restoration of vascular integrity after damage.
Why Is positive regulation of vascular wound healing Important in Cell Biology?
Positive regulation of vascular wound healing is fundamental to tissue repair and regeneration, as it ensures adequate blood supply to injured tissues. Its dysregulation contributes to a wide range of pathologies, including tumor angiogenesis, chronic non-healing wounds, and impaired bone regeneration. Targeting this process holds therapeutic potential for promoting wound healing, treating ischemic diseases, and inhibiting cancer progression. Moreover, understanding the molecular players involved can inform the development of novel regenerative medicine strategies.
• Promotes tissue repair by restoring blood flow to damaged areas.
• Supports bone regeneration through skeletal endothelial cells.
• Plays a role in tumor angiogenesis, contributing to cancer progression.
• Is essential for chronic wound healing, where impaired angiogenesis leads to non-healing ulcers.
• Influences scar formation and fibrotic microenvironment.
• Involves mechanotransduction pathways that sense matrix stiffness.
• Crosstalk with immune cells, such as macrophages, modulates the regenerative response.
• Provides targets for therapeutic intervention in ischemic diseases and cancer.
• Requires precise regulation; excessive or insufficient activity can lead to pathology.
• CRISPR-based models enable functional dissection of genes in this process.
What Happens During positive regulation of vascular wound healing?
Initiation by Injury Signals
In simple terms: When blood vessels are damaged, the body sends signals to start the repair process.
Vascular injury triggers the release of pro-inflammatory cytokines and growth factors that recruit immune cells and activate endothelial cells. This initial phase sets the stage for subsequent angiogenesis and vascular remodeling. Macrophages play a key role by secreting factors that promote endothelial cell proliferation and migration.
Endothelial Cell Activation and Proliferation
In simple terms: Endothelial cells, which line blood vessels, start to multiply and move to form new vessels.
Upon stimulation, endothelial cells switch to a proliferative and migratory phenotype. Mechanotransduction via Piezo1 senses matrix stiffness and activates signaling pathways that drive angiogenesis in hepatocellular carcinoma. Skeletal endothelial cells also support bone regeneration by promoting angiogenesis. This step is critical for expanding the endothelial cell pool needed for new vessel formation.
Sprouting and Tube Formation
In simple terms: New blood vessels sprout from existing ones and form tubes.
Activated endothelial cells degrade the basement membrane, migrate, and form sprouts that eventually coalesce into tubes. This process is tightly regulated by growth factors and extracellular matrix components. In chronic wounds, immunomodulatory hydrogels can orchestrate macrophage-driven angiogenesis to enhance tube formation.
Maturation and Stabilization
In simple terms: The new vessels mature and become stable to restore blood flow.
Newly formed vessels recruit pericytes and smooth muscle cells to stabilize the structure. This maturation phase involves the deposition of extracellular matrix and remodeling of the vascular network. In scar management, CAR-TREM2-macrophages regulate the fibrotic microenvironment to promote proper vessel maturation.
Resolution and Restoration of Integrity
In simple terms: The repair process ends, and the blood vessel is fully healed.
Once the vascular integrity is restored, the angiogenic signals subside, and the endothelium returns to a quiescent state. Failure to resolve can lead to pathological angiogenesis, as seen in cancer. Proper resolution is essential for preventing excessive scarring and fibrosis.
Key Genes Involved in GO:0035470 positive regulation of vascular wound healing
The following genes and proteins are key players in positive regulation of vascular wound healing, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Piezo1 | Mechanosensitive ion channel that senses matrix stiffness and promotes angiogenesis | Target for cancer and wound healing studies |
| TREM2 | Regulates macrophage polarization and fibrotic microenvironment | Involved in scar management and chronic wound healing |
| VEGFA | Key growth factor driving endothelial cell proliferation and migration | Central to angiogenesis and vascular repair |
| NF-κB | Transcription factor regulating inflammatory and angiogenic genes | Modulated by ROC1 in bladder cancer |
| ROC1 | Promotes malignant progression via p-IκBα/NF-κB signaling | Potential target in bladder cancer |
| CXCR4 | Chemokine receptor involved in endothelial cell recruitment | Studied in lymphangiogenesis and wound healing |
| TIE2 | Receptor tyrosine kinase for angiopoietins, stabilizes vessels | Important for vascular maturation |
| PDGFB | Recruits pericytes and smooth muscle cells | Critical for vessel stabilization |
| HIF1A | Hypoxia-inducible factor driving angiogenic gene expression | Key regulator under ischemic conditions |
| MMP9 | Matrix metalloproteinase degrading extracellular matrix | Facilitates endothelial cell migration |
| CD31 | Endothelial cell adhesion molecule | Marker for endothelial cells in angiogenesis assays |
| CDH5 | Vascular endothelial cadherin, maintains endothelial junctions | Essential for vascular integrity |
| ACTA2 | Smooth muscle actin, marker of mural cells | Indicates vessel maturation |
| COL1A1 | Collagen type I, major extracellular matrix component | Supports vessel stability and wound healing |
| FN1 | Fibronectin, promotes cell adhesion and migration | Involved in matrix remodeling |
| IL6 | Pro-inflammatory cytokine modulating angiogenesis | Links inflammation and vascular repair |
| TNF | Tumor necrosis factor, regulates endothelial cell activation | Context-dependent effects on angiogenesis |
How Is positive regulation of vascular wound healing Regulated?
Positive regulation of vascular wound healing is tightly controlled by multiple signaling pathways. Mechanotransduction via Piezo1 activates downstream effectors in response to matrix stiffness, promoting angiogenesis in hepatocellular carcinoma. Inflammatory cytokines such as IL6 and TNF modulate endothelial cell activation and macrophage polarization. The NF-κB pathway, regulated by ROC1, influences angiogenic gene expression in bladder cancer. Additionally, metabolic regulators like metformin can impact angiogenesis through lncRNA-mediated pathways in non-small cell lung cancer. Immune cells, particularly macrophages, play a dual role in regulating angiogenesis and fibrosis, as seen with CAR-TREM2-macrophages in scar management. These regulatory mechanisms ensure that vascular wound healing is appropriately initiated and resolved.
positive regulation of vascular wound healing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Piezo1 | Hepatocellular carcinoma, angiogenesis | Knockout and overexpression in liver cancer cell lines |
| TREM2 | Scar formation, chronic wounds | Knock-in and knockout in macrophage models |
| ROC1 | Bladder cancer progression | Knockdown and overexpression in bladder cancer cells |
| VEGFA | Ischemic diseases, wound healing | Conditional knockout in endothelial cells |
| HIF1A | Hypoxia-induced angiogenesis | Point mutation and knockout in cancer models |
Cancer Progression and Tumor Angiogenesis
Positive regulation of vascular wound healing is hijacked in cancer to support tumor growth and metastasis. Piezo1 activation by matrix stiffness promotes angiogenesis in hepatocellular carcinoma, contributing to malignant progression. ROC1 promotes bladder cancer progression by regulating p-IκBα/NF-κB signaling, which can influence angiogenic gene expression. Metformin inhibits non-small cell lung cancer via lncRP11-242D8.1, potentially affecting angiogenesis. Targeting these pathways may provide therapeutic benefits.
Chronic Wounds and Impaired Healing
Chronic wounds, such as diabetic ulcers, are characterized by impaired angiogenesis and prolonged inflammation. Immunomodulatory hydrogels can orchestrate pro-regenerative macrophage responses and angiogenesis to promote healing. Dysregulation of vascular wound healing contributes to non-healing wounds, highlighting the need for therapies that enhance this process.
Bone Loss and Skeletal Regeneration
Skeletal endothelial cells are critical for bone regeneration, and targeting them can ameliorate bone loss. Positive regulation of vascular wound healing in the bone microenvironment supports osteogenesis and fracture repair. Therapeutic strategies that promote angiogenesis may enhance bone healing.
Scar Formation and Fibrosis
Excessive vascular wound healing can lead to scar formation and fibrosis. CAR-TREM2-macrophages regulate the fibrotic microenvironment, offering a strategy for scar management. Balancing angiogenesis and fibrosis is essential for optimal tissue repair.
From positive regulation of vascular wound healing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does Piezo1 promote angiogenesis in hepatocellular carcinoma? | Piezo1 knockout and overexpression in HCC cell lines |
| Can targeting skeletal endothelial cells ameliorate bone loss? | Endothelial-specific knockout of target genes in mouse models |
| What is the role of TREM2 in scar management? | CAR-TREM2-macrophage knock-in and knockout models |
| How does ROC1 regulate NF-κB signaling in bladder cancer? | ROC1 knockdown and overexpression in bladder cancer cells |
| Does metformin inhibit NSCLC via lncRP11-242D8.1? | lncRNA knockout and overexpression in NSCLC cells |
| What is the effect of VEGFA on vascular wound healing? | Inducible endothelial-specific VEGFA knockout mice |
How to Study the positive regulation of vascular wound healing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene function loss-of-function | Identify novel regulators of angiogenesis |
| RNA-seq | Transcriptional changes | Profile gene expression during wound healing |
| Proteomics | Protein abundance and modifications | Dissect signaling pathways |
| Phosphoproteomics | Phosphorylation events | Map kinase cascades |
| Matrigel plug assay | In vivo angiogenesis | Evaluate pro-angiogenic factors |
| Hindlimb ischemia model | Blood flow recovery | Test therapeutic angiogenesis |
| Immunohistochemistry | Protein localization and expression | Assess vessel density and maturation |
| Flow cytometry | Cell population analysis | Characterize immune cell infiltration |
CRISPR-Cas9 Knockout Screening
Genome-wide CRISPR knockout screens can identify genes that positively regulate vascular wound healing. For example, targeting Piezo1 in hepatocellular carcinoma cells revealed its role in matrix stiffness-induced angiogenesis. This method allows unbiased discovery of novel regulators.
RNA Sequencing and Transcriptomics
RNA-seq can profile gene expression changes during vascular wound healing. Studies on immunomodulatory hydrogels have used transcriptomics to uncover macrophage-driven angiogenic programs. This approach helps identify pathways and biomarkers.
Proteomics and Phosphoproteomics
Proteomic analyses can reveal signaling networks activated during angiogenesis. For instance, ROC1 regulation of p-IκBα/NF-κB signaling was dissected using phosphoproteomics. This method provides insights into post-translational modifications.
In Vivo Angiogenesis Assays
Matrigel plug assays, corneal micropocket assays, and hindlimb ischemia models are used to assess vascular wound healing in vivo. Skeletal endothelial cell targeting was validated in bone loss models. These assays are critical for translational research.
How CRISPR Can Be Used to Study GO:0035470 positive regulation of vascular wound healing
Knockout
CRISPR knockout is used to ablate genes involved in vascular wound healing to assess loss-of-function phenotypes. For example, Piezo1 knockout in hepatocellular carcinoma cells reduced matrix stiffness-induced angiogenesis. Skeletal endothelial cell knockout models have been used to study bone loss. This approach is fundamental for target validation.
Point Mutation
Point mutations can be introduced to study specific amino acid residues critical for protein function. For instance, mutating phosphorylation sites in ROC1 could elucidate its role in NF-κB signaling. This precision editing helps dissect molecular mechanisms.
Knock-in
Knock-in models allow tagging or replacement of endogenous genes with modified versions. CAR-TREM2-macrophage knock-in models have been developed for scar management. This technique is useful for tracking protein localization and function.
Overexpression
Overexpression of pro-angiogenic factors such as VEGFA can enhance vascular wound healing in disease models. Conversely, overexpression of oncogenes like ROC1 promotes malignant progression. This approach helps identify gain-of-function effects.
How EDITGENE Supports positive regulation of vascular wound healing Research
Researchers studying positive regulation of vascular wound healing-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise functional genomics in this field.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of vascular wound healing research.
Frequently Asked Questions About positive regulation of vascular wound healing
What is GO:0035470?
GO:0035470 is the Gene Ontology term for positive regulation of vascular wound healing, defined as any process that increases the rate, frequency, or extent of blood vessel formation from pre-existing vessels to restore damaged vasculature.
What genes are involved in positive regulation of vascular wound healing?
Key genes include Piezo1, TREM2, VEGFA, ROC1, and HIF1A, among others.
How is positive regulation of vascular wound healing studied?
It is studied using CRISPR knockout screens, RNA-seq, proteomics, and in vivo angiogenesis assays.
What diseases are associated with dysregulated vascular wound healing?
Cancer, chronic wounds, bone loss, and scar formation are associated with dysregulation of this process.
What is the role of Piezo1 in vascular wound healing?
Piezo1 is a mechanosensitive ion channel that senses matrix stiffness and promotes angiogenesis in hepatocellular carcinoma.
How do macrophages contribute to vascular wound healing?
Macrophages secrete pro-angiogenic factors and can be polarized to a pro-regenerative phenotype, as seen with CAR-TREM2-macrophages.
Can CRISPR be used to study vascular wound healing?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in this process.
What is the connection between bone loss and vascular wound healing?
Skeletal endothelial cells support bone regeneration, and targeting them can ameliorate bone loss.
How does matrix stiffness affect angiogenesis?
Matrix stiffness activates Piezo1, which triggers signaling pathways that promote angiogenesis.
What are the therapeutic implications of targeting vascular wound healing?
Therapies can be developed for cancer, chronic wounds, bone loss, and scarring by modulating this process.
Conclusion
Positive regulation of vascular wound healing (GO:0035470) is a critical biological process with broad implications for tissue repair and disease. Key molecular players such as Piezo1, TREM2, and VEGFA have been identified through rigorous research. Dysregulation of this process contributes to cancer, chronic wounds, and bone loss, making it an attractive therapeutic target. Advances in CRISPR-based models and bioinformatics are accelerating our understanding of the underlying mechanisms. EDITGENE's comprehensive services empower researchers to dissect gene function and develop novel interventions for vascular wound healing-related pathologies.
References
- 1. Li M et al.. 2022. Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma.. Cancer Commun (Lond) 42(11):1162-1184 PMID: 36181398
- 2. Xu R et al.. 2018. Targeting skeletal endothelium to ameliorate bone loss.. Nat Med 24(6):823-833 PMID: 29785024
- 4. Kuan CH et al.. 2025. Immunomodulatory hydrogel orchestrates pro-regenerative response of macrophages and angiogenesis for chronic wound healing.. Biomaterials 314:122848 PMID: 39342917
- 5. Liu M et al.. 2024. A Strategy Involving Microporous Microneedles Integrated with CAR-TREM2-Macrophages for Scar Management by Regulating Fibrotic Microenvironment.. Adv Mater 36(49):e2406153 PMID: 39313983
- 6. Wu Q et al.. 2021. ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling.. J Exp Clin Cancer Res 40(1):158 PMID: 33962660
- 7. Sáinz-Jaspeado M et al.. 2018. Cytokines regulating lymphangiogenesis.. Curr Opin Immunol 53:58-63 PMID: 29680577
- 8. Tian X et al.. 2026. Metformin inhibits non-small cell lung cancer via lncRP11-242D8.1.. Arch Biochem Biophys 778:110751 PMID: 41643885
